Related Experiment Video
Updated: Apr 7, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
Treating dyslipidemia in patients with type 2 diabetes mellitus
Michelle L Frank1, Annie M Gerhardt
1Michelle L. Frank is a family nurse practitioner student at University of Mary, Bismarck, N.D. Annie M. Gerhardt is adjunct faculty at the University of Mary, Bismarck, N.D. and a family nurse practitioner at Altru Clinic Lake Region, Devils Lake, N.D.
Abstract:
Type 2 diabetes mellitus is associated with significant cardiovascular morbidity and mortality. Diabetic dyslipidemia is a major cause of cardiovascular complications and a key area for intervention. The blood cholesterol treatment guideline released in 2013 and strategies to reduce cardiovascular risk are outlined and addressed in this article.
More Related Videos
Related Concept Videos
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Atherosclerosis III: Management
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes Mellitus: Type 2 and Gestational
Angina IV: Management
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
